This expert outsourcing report is a comprehensive look at the pharmaceutical manufacturing landscape for emerging markets in Q1 2026, including analysis of news and trends affecting contract manufacturing organizations (CMOs) and the identification of recent contract service agreements, mergers, acquisitions, and financing among CMOs. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the pharmaceutical value chain that will provide insights into API (biologics and chemical) as well as dose manufacturing and packaging (clinical and commercial) for countries in emerging markets.
Report Scope
This report gives an important monthly update on the pharmaceutical outsourcing industry, based on analysis from the analyst's experts and our databases covering deals, companies, drugs, financials, news, clinical trials, and more. This report is required reading for:- CMO executives and strategic decision-makers: to improve understanding of the CMO industry and provide a critical input for strategic planning efforts.
- Sourcing and procurement executives in bio/pharmaceutical companies: to improve understanding of crucial components of the supply base that will provide insights for supplier selection and management.
- Investors, advisors, and consultants: they can gain a deeper understanding of the CMO market and important insights for identifying potential investment targets.
Reasons to Buy
- Understand current trends and equip yourself with forward-thinking strategies to navigate challenges and capitalise on emerging trends driving the pharmaceutical manufacturing industry. Use our radar to identify developments and innovations with high impact.
- Discover the latest opportunities and threats in the contract manufacturing industry, based on clinical trials and regulatory decisions.
- Learn about the past quarter’s M&A and financing deals in the manufacturing space.
- Identify the latest contract service agreements.
- Develop your competitor or market intelligence by reading about inspection outcomes and facility investments.
- Stay ahead of disruption with updates on supply chain obstacles and new regulations.
Table of Contents
1 Industry Trends
2 Industry Analysis
3 Value Chain
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie
- Akari Therapeutics Plc
- Akums Drugs & Pharmaceuticals Ltd
- Alembic Pharmaceuticals Ltd
- Alfresa
- Alfenax
- Amaran Biotechnology Inc
- Anupam Rasayan India Ltd
- Aragen Life Sciences Ltd
- Arna Pharma Pty Ltd
- AstraZeneca
- Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY)
- Bayer
- BeOne Medicines
- Beijing Gene Mink Biotechnology Co Ltd
- Bharat Biotech Ltd
- Bliss GVS Pharma Ltd
- Bristol Myers Squibb
- Caplin Point Laboratories Ltd
- Central Drugs Standard Control Organisation (CDSCO)
- CHA Biotech Co Ltd
- Chime Biologics Ltd
- Chemspec Chemicals Ltd
- Cintrade Co Ltd
- Cohance Lifesciences Ltd
- Corona Remedies Ltd
- Earendil Labs Inc
- Eli Lilly
- Emcure Pharmaceuticals Ltd
- Enzene Biosciences Ltd
- Esco Aster Pte Ltd
- Eurasian Economic Union (EAEU)
- European Medicines Agency (EMA)
- Extractas Bioscience
- Formosa Laboratories Inc
- Fundação Butantan
- Granules India Ltd
- HanchorBio Inc
- Hanwha Life Insurance Co Ltd
- Henlius Biotech
- ImmunoACT
- Indoco Remedies Ltd
- Instituto Butantan
- IPCA Laboratories Ltd
- Israel Innovation Authority (IIA)
- Jiangsu Sinorda Biomedicine Co Ltd
- Johnson & Johnson
- LG CNS Co Ltd
- Lupin Ltd
- Lupin Manufacturing Solutions Ltd
- Morepen Laboratories Ltd
- Mycenax Biotech Inc
- National Medical Products Administration (NMPA)
- Ningxia Taiyicin Biotech Co Ltd
- Noramco Inc
- Novartis
- Panacea Biotec Ltd
- Pfizer
- Piramal Pharma Solutions Inc
- Pluri Inc
- PolyPeptide Group AG
- Porton Pharma Solutions Ltd
- Purisys
- Qatar Free Zones Authority
- Recipharm AB
- Recipharm Israel Ltd
- Remedy Cell Ltd
- Scinai Immunotherapeutics Ltd
- Shanghai Asymchem Biologics Co Ltd
- Shanghai Junshi Biosciences
- Shine-On BioMedical Co Ltd
- Siegfried Holding AG
- Slate Run Pharmaceuticals LLC
- Sm Biomed Sdn Bhd
- Solopharm
- State Council (China)
- Takeda's
- TFBS Bioscience Inc
- TNAX Biopharma Corp
- Tottori University
- Unichem Laboratories Ltd
- US Food and Drug Administration (FDA)
- Viatris Inc
- WuXi Biologics Cayman Inc
- WuXi Biologics Co Ltd
- WuXi Vaccines Co Ltd
- WuXi XDC Cayman Inc
- Xi'an Libang Pharmaceuticals Co Ltd
